Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. (Q54578505)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. |
scientific article |
Statements
Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide (English)
Murielle Mimeault
Sonny L Johansson
Erik Moore
Jean-Pierre Henichart
Patrick Depreux
Ming-Fong Lin
Surinder K Batra
1 January 2007
1 reference
1 reference
1 reference